HEPAVIXA
30 Tablets — Blister Pack
L-ornithine L-aspartate with choline, L-methionine and inositol in 30-tablet blister packs. Supplied for private-label and contract manufacturing orders.
- Therapeutic area
- Hepatology
- Active ingredients
- L-ornithine L-aspartate 250 mg · Choline 52 mg · L-methionine 40 mg · Inositol 50 mg
- Suggested use
- 1–2 tablets daily, or as directed by a healthcare professional.
- Form
- Tablet
Supplement Facts
| Ingredient | Amount |
|---|---|
| L-ornithine L-aspartate | 250 mg |
| Choline | 52 mg |
| L-methionine | 40 mg |
| Inositol | 50 |
| Servings per container: 30 | |
HEPAVIXA is a combination tablet containing L-ornithine L-aspartate 250 mg, choline 52 mg, L-methionine 40 mg and inositol 50 mg per tablet, supplied in 30-tablet blister packs.
The product is offered for private-label and contract manufacturing projects. Composition, packaging, labelling and product documentation are agreed per destination market.
Claim wording and permitted positioning differ by market. Final label text is agreed with the buyer's regulatory advisor.